Simulating the anhedonia symptom of depression in animals

Dialogues in Clinical Neuroscience

Volumn 4, Issue 4, 2002, Pages 351-360

  Moreau, Jean Luc ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Anhedonia; Chronic mild stress; Depression; Model; Rat

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BROFAROMINE; CHLORDIAZEPOXIDE; CHLORPROTHIXENE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MAPROTILINE; MIANSERIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE; SERTRALINE; SUCROSE; VENLAFAXINE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE SIMULATION; ELECTRIC SHOCK; EMOTIONAL STRESS; HUMAN; LIFE EVENT; NONHUMAN; PATHOPHYSIOLOGY; PLACE PREFERENCE; PSYCHOPHARMACOLOGY; RAT; REINFORCEMENT; REWARD; SELF STIMULATION; SLEEP DISORDER; SUGAR INTAKE; SYMPTOM; VALIDATION PROCESS; VENTRAL TEGMENTUM;

EID: 0038330782     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Mckinney WT. Animal models of depression: an overview. Psychiatr Dev. 1984;2:77-96.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Akiskal HS. A developmental perspective on recurrent mood disorders: a review of studies in man. Psychopharmacol Bull. 1986;22:579-586.
4. Willner P. Depression: a psychobiological synthesis. New York, NY: Wiley; 1985.
5. Aneshensel CS, Stone JD. Stress and depression: a test of the buffering model of social support. Arch Gen Psychiatry. 1982;39:1392-6.
6. Lloyd C. Life events and depressive disorder reviewed. II. Events as precipitating factors. Arch Gen Psychiatry. 1980;37:541-548.
7. Billings AG, Cronkite RC, Moos RH. Social-environmental factors in unipolar depression: comparisons of depressed patients and non-depressed controls. J Abnorm Psychol. 1983;92:119-133.
8. Nelson JC, Charney DS. The symptoms of major depression. Am J Psychiatry. 1981;138:1-13.
9. Katz RJ. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav. 1982;16:965-968.
10. Katz RJ, Sibel M. Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds. Pharmacol Biochem Behav. 1982;16:973-977.
11. Willner P, Towell, A, Sampson D, et al. Reduction of sucrose preference by chronic unpredictable mild stress, and restoration by tricyclic antidepressant. Psychopharmacology. 1987;93:358-364.
12. Moreau JL, Bos M, Jenck F, Martin JR, Mortas P, Wichmann J. Eur Neuropsychopharmacol. 1996;6:169-175.
13. Matthews K, Forbes N, Reid IC. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol Behav. 1995;57:241-248.
14. Papp M, Willner P, Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology. 1991;104:255-259.
15. Rosellini RA, De Cola JP, Plonsky M, et al. Uncontrollable shock proactively increases sensitivity to response-reinforcer independence in rats. J Exp Psychol Anim Behav Process. 1984;10:346-359.
16. Minor TR, Pelleymounter MA, Maier SF. Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: evidence for a deficit in selective attention. J Exp Psychol. 1988;10:543-556.
17. Markou A, Koob GF. Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology. 1991;4:17-25.
18. Fibiger HC, Phillips AG. Role of catecholamine transmitters in brain reward systems: implications for the neurobiology of affect. In: Engel J, Oreland L, eds. Brain Reward Systems and Abuse. New York, NY: Raven Press; 1987:61-74.
19. Moreau JL, Jenck F, Martin JR, et al. Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol. 1992;2:43-49.
20. Moreau JL, Jenck F, Martin JR, Mortas P, Haefely W. Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry. 1993;26:30-33.
21. Moreau JL, Bourson A, Jenck F, Martin JR, Mortas P. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J Psychiatry Neurosci. 1994;19:51-56.
22. Avery D, Winokur G. The efficacy of electroconvulsive therapy and antidepressants in depression. Biol Psychiatry. 1977;12:507-523.
23. Fink M. Indication for the use of electroconvulsive therapy. Psychopharmacol Bull. 1994;30:269-275.
24. Moreau JL, Scherschlicht R, Jenck F, Martin JR. Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol. 1995;6:682-687.
25. Abrams R. Out of the blue: the rehabilitation of electroconvulsive therapy. Sciences (New York). 1989;29:24-30.
26. Moreau JL, Jenck F, Martin JR. Simulation of a core symptom of human depression in rats. Curr Topics Pharmacol. 1998;4:37-50.
27. Muscat R, Papp M, Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants fluoxetine and maprotiline. Psychopharmacology. 1992;109:433-438.
28. Papp M, Moryl E, Willner P. Pharmacological validation of the chronic mild stress model of depression. Psychopharmacology. 1996;296:129-136.
29. Brown GW. Life events and affective disorders: replications and limitations. Psychosom Med. 1993;55:248-259.
30. Gillin JC, Wyatt RJ, Fram D, et al. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology. 1978;59:267-272.
31. Kupfer DJ, Thase ME. The use of the sleep laboratory in the diagnosis of affective disorders. Psychiatr Clin North Am. 1983;6:3-25.
32. Reynolds CF, Kupfer DJ, Houck PR, et al. Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data. Arch Gen Psychiatry. 1988;45:258-264.
33. Steiger A, von Bardeleben U, Guldner J, Lauer C, Rothe B, Holsboer F. The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS active drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:125-137.
34. Reynolds CF, Kupfer DJ. Sleep research in affective illness, state of the art circa 1987. Sleep. 1987;10:199-215.
35. Rush AJ, Erman MK, Giles DE. Polysomnographic findings in recent drug-free and clinically remitted depressed patients. Arch Gen Psychiatry. 1986;43:878-884.
36. Willner P, Wilkes M, Orwin O. Attributional style and perceived stress in endogenous and reactive depression. J Affect Dis. 1990;18:281-287.
37. D'aquila P, Brain P, Willner P. Effects of chronic mild stress on performance in behavioral tests relevant to anxiety and depression. Physiol Behav. 1994;56:861-867.
38. Ayensu WT, Pucilowski O, Mason GA, et al. Effects of chronic mild stress on serum complement activity, saccharin preference and corticosterone levels in Flinders lines of rats. Physiol Behav. 1995;57:165-169.
39. Cheeta S, Broekkamp CLE, Willner P. Stereospecific reversal of stress-induced anhedonia by mianserin and its (+) enantiomer. Psychopharmacology. 1994;116:523-528.
40. Sluzewska A, Nowakowska E. The effects of carbamazepine, lithium and ketoconazole in chronic mild stress model of depression in rats. Behav Pharmacol. 1994;5(suppl 1):86.
41. Gorka Z, Moryl E, Papp M. Chronic mild stress influences the diurnal activity rhythms in rats. Behav Pharmacol. 1994;5(suppl 1):88.
42. Thiebot MH, Martin P, Puech AJ. Animal behavioural studies in the evaluation of antidepressant drugs. Br J Psychiatry. 1992;15:44-50.